SRB Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SRB Corp's PFE Position: Q2 2023 in Review
SRB Corp sold out of Pfizer (PFE) in Q2 2023, closing a stake of 8,496 shares — an estimated $347K sold.
SRB Corp first reported a position in PFE in Q3 2014 and held it in 21 quarters. The position peaked at $1.68M in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- SRB Corp reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
- SRB Corp sold 8,496 Pfizer shares in Q2 2023, an estimated $347K.
- SRB Corp first reported a position in Pfizer in Q3 2014 and held it in 21 quarters.
- SRB Corp's Pfizer position peaked at $1.68M in Q4 2021.
- 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on SRB Corp's 13F filing for Q2 2023, filed 14 Aug 2023.